MenoVantage PE 90 vcaps

MenoVantage PE 90 vcaps

Free shipping
On most orders over $300 within the continental USA
Quantity in stock
No items available
90 vcaps
Market price:
Our Price:
Out of stock
Questions? Call 408-354-4262
- or -
  • Details
  • Ingredients
  • Send to friend
  • Customer feedback
Save 15%

MenoVantage PE 90 vcaps | Bioclinic Naturals

MenoVantage PE is for the reduction of hot flashes, night sweats and other symptoms of menopause*

For many women the transition from pre- to post-menopause can be arduous. Changing hormone levels can lead to increased risk for both heart disease and osteoporosis,1,2 while inducing uncomfortable shorter term issues such as vasomotor symptoms (hot flushes, night sweats), insomnia, vaginal dryness, mood changes and reduction in libido. Although estrogen replacement therapy (ERT) may reduce some of the aforementioned concerns, the Women’s Health Initiative has shown that ERT use in post-menopausal women is linked to an increased risk of both breast cancer and cardiovascular disease.3 However, phytoestrogens provide a viable alternative to ERT. While they share the basic chemical framework of other steroid hormones, potencies are approximately 1000-fold weaker than that of 17-a estradiol.4 It is estimated that more than 300 plants contain compounds with estrogenic activity including those found in MenoVantage PE. These include the herbs black cohosh (Actaea racemosa) and Dong quai (Angelica sinensis) which have been shown clinically to reduce menopausal symptoms.5,6*
  • Standardized herbal extracts*
  • Potent phytoestrogens: Angelica sinensis and Actaea racemosa*
  • Normalizes LH and FSH through the action of Vitex agnus-castus7,8*
  • Gamma-Oryzanol reduces climacteric symptoms and increases HDL-C9*
  • Hesperidin, a citrus bioflavonoid, helps decrease vasomotor activity along with vitamin C10*
  • Vegetarian capsule*
  1. Matthews KA. et al. Menopause and Risk Factors for Coronary Heart Disease. N Engl J Med. 1989; 321:641-646.*
  2. Christenson ES, Jiang X, Kagan R, Schnatz P. Osteoporosis management in post-menopausal women. Minerva Ginecol. 2012;64:181-94.*
  3. Grimes DA, Lobo RA. Perspectives on the Women’s Health Initiative Trial of Hormone Replacement Therapy. Obstet Gynecol. 2002;100:1344–53.*
  4. Sunita P, Pattanayak SP. Phytoestrogens in postmenopausal indications: A theoretical perspective. Pharmacogn Rev. 2011;5:41-7.*
  5. Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin HH. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol. 2005;105(5 Pt 1):1074-83.*
  6. Kupfersztain C, Rotem C, Fagot R, Kaplan B. The immediate effect of natural plant extract, Angelica sinensis and Matricaria chamomilla (Climex) for the treatment of hot flushes during menopause. A preliminary report. Clin Exp Obstet Gynecol. 2003;30:203-6.*
  7. Nasri S, Oryan S, Haeri Rohani A, Amin GH, Yahyavi H. The Effects of Vitex agnus castus L. Extract on Gonadotrophines and Testosterone in Male Mice.Iranian Int. J. Sci. 2004,5:25-30.*
  8. van Die MD, Burger HG, Teede HJ, Bone KM. Vitex agnus-castus (Chaste-Tree/Berry) in the treatment of menopause-related complaints. J Altern Complement Med. 2009;15:853-62.*
  9. Ishihara M, Ito Y, Nakakita T, Maehama T, Hieda S, Yamamoto K, Ueno N. [Clinical effect of gamma-oryzanol on climacteric disturbance -on serum lipid peroxides (author’s transl)]. [Article in Japanese] Nihon Sanka Fujinka Gakkai Zasshi. 1982;34:243-51.*
  10. Smith CJ. Non-hormonal control of vaso-motor flushing in menopausal patients.Chic Med. 1964;67:193-5.*
  11. Teschke R, Schwarzenboeck A, Schmidt-Taenzer W, Wolff A, Hennermann KH. Herb induced liver injury presumably caused by black cohosh: a survey of initially purported cases and herbal quality specifications. Ann Hepatol. 2011;10:249-59.*
  12. Duffy C, Perez K, Partridge A. Implications of phytoestrogen intake for breast cancer. CA Cancer J Clin. 2007;57:260-77.*
  13. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Khan IA, Shah A. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther. 2005;77:415-26.*
  14. Shi S, Klotz U. Drug interactions with herbal medicines. Clin Pharmacokinet. 2012;51:77-104. doi: 10.2165/11597910-000000000-00000.*
  15. Dugoua JJ, Seely D, Perri D, Koren G, Mills E. Safety and efficacy of chastetree (Vitex agnus-castus) during pregnancy and lactation. Can J Clin Pharmacol. 2008;15:e74-*

MenoVantage PE 90 vcaps | Bioclinic Naturals

MenoVantage PE 90 vcaps
Serving Size 2 Capsules 
Servings Per Container 45

Amount Per Serving  
Dong Quai Extract (Angelica sinensis) (root)....................................200 mg  
Chasteberry Extract (Vitex agnus-castus) (fruit) .............................160 mg 
Black Cohosh Extract (Actaea racemosa) (root) ..............................160 mg 
(2.5% triterpene glycosides as 27-deoxyacteine) 
Gamma-Oryzanol (Oryza sativa) (seed bran) ..................................150 mg  
Hesperidin .......................................................................................75 mg 

Other ingredients: Vegetarian capsule (carbohydrate gum [cellulose], purified water), microcrystalline cellulose, gum arabic, magnesium stearate (vegetable grade) and silica.
2 capsules at breakfast and 2 at bedtime per day or as directed by a health care professional. Consult a health care professional for use beyond one year. Keep out of reach of children.
Consult a health care professional if symptoms persist or worsen. Consult a health care professional prior to use if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy, if you are breastfeeding, or if you have a liver disorder or develop symptoms of liver trouble.11Do not use if you have a history of hormone dependent cancers.12
Additional Information
Do not use if you are using anticoagulant/antiplatelet medications (warfarin; Ticlid).13As black cohosh may interact with CYP2E1 and CYP2D6 substrates, practitioners should be aware of potential drug interactions.14 The use of vitex is contraindicated in conjunction with bromocriptine, metaclopramide, dopamine agonists and antipsychotic drugs
This field is required
A valid email is required
A valid email is required
This field is required
There have been no reviews

Add your own review
  • Disclaimer

*Your results may vary from those listed above.

*These statements have not been evaluated by the Food and Drug Administration.
*This product is not intended to diagnose, treat, cure or prevent any disease.

Since we do not know everything about your medical history and medications, please consult with your health care practitioner before implementing any new protocols and supplements. Do not construe any information listed on this site as a substitute for actual medical advice. The info you receive from us is not intended to replace medical advice by your doctor. Forrest Health, Inc. does not dispense medical advice, prescribe, or diagnose illness. We offer nutritional programs and supplements that support your health. The views and nutritional advice expressed by Forrest Health, Inc. are not intended to be a substitute for conventional medical service. If you have a medical condition, see your physician of choice.